There is a version of the gut health conversation I find frustrating — the one that begins and ends with probiotics, or with vague advice to eat more fibre and stress less. That version treats the gut as a plumbing problem. But the microbiome is not plumbing. It is, in many ways, a second nervous system, a co-regulator of your immune response, and one of the most powerful dials we have access to when it comes to biological ageing.
What I want to do here is give you a more honest picture. Not a supplement pitch. Not a detox protocol. A clear-eyed look at what the science actually says about the relationship between your gut bacteria and how fast you age — and what that means in clinical practice.
"The gut is where the body's conversation with the outside world begins. Every meal, every stressor, every antibiotic course writes a line in that conversation. Learning to read it — that is where genuine longevity medicine starts."Dr. Sadaf Mubeen Mirza — Longyx
Scale: what we are actually talking about
The human gut contains approximately 38 trillion microbial cells — a number that roughly matches, and by some estimates exceeds, the total number of human cells in the body. These organisms collectively carry about 150 times more unique genes than the entire human genome. We are, metabolically speaking, more microbial than we are human.
The vast majority live in the colon. They are dominated by bacteria, but also include archaea, fungi, viruses, and phages — all interacting in a dense, competitive, mutually regulating ecosystem. This ecosystem has a name: the gut microbiome. And it has been shaped by every meal you have eaten, every antibiotic you have taken, every environment you have lived in, and the microbiomes of the people who raised you.
A note on terminology. "Microbiota" refers to the organisms themselves. "Microbiome" technically refers to the organisms plus their collective genetic material and environment — though the two terms are now used interchangeably in clinical literature. When we talk about assessing the gut microbiome, we are talking about characterising this entire ecosystem: who is present, in what proportions, and what they are producing.
The Gut-Brain Axis: your bacteria are listening to your thoughts
The vagus nerve carries roughly 100,000 nerve fibres, and about 80 to 90 percent of its signalling traffic runs upward — from gut to brain, not the other way around. This is not a metaphor. Your gut bacteria directly influence what those signals say.
Gut microbes produce or stimulate the production of a remarkable array of neuroactive compounds. Approximately 90% of the body's serotonin is synthesised in the gut, with specific bacterial species — particularly from the Clostridia class — stimulating enterochromaffin cells to do so. GABA, the brain's primary calming neurotransmitter, is produced by Lactobacillus and Bifidobacterium species. Short-chain fatty acids (more on these shortly) cross the blood-brain barrier and influence microglial activity — the immune cells of the brain.
What this means clinically is significant. Dysbiosis — an imbalanced, low-diversity microbiome — is associated with elevated neuroinflammation, disrupted sleep architecture, increased anxiety, and cognitive decline. These are not downstream consequences of a sick gut. They are, in part, direct outputs of an altered microbial ecosystem.
The Sonnenburg Lab at Stanford has been central to establishing the mechanistic links between diet, microbiome composition, and immune function. A landmark 2021 paper in Cell by Wastyk, Sonnenburg et al. demonstrated that a high-fermented-food diet — not just high-fibre — significantly increased microbiome diversity and decreased markers of systemic inflammation, including 19 inflammatory proteins. This was one of the first randomised trials to show a causal effect of diet on the microbiome and a measurable immunological response in healthy adults.
The Gut-Immune Axis: 70% of your immune system lives here
Approximately 70 to 80 percent of the body's immune tissue — gut-associated lymphoid tissue, or GALT — lines the gastrointestinal tract. This is not an accident of anatomy. The gut wall is the largest surface of contact between the body and the external environment. Every meal is, immunologically speaking, a foreign encounter. The microbiome is the interface that negotiates it.
Healthy gut bacteria train regulatory T cells to distinguish between harmless food proteins and genuine threats. They produce metabolites that reinforce the epithelial tight junctions — the physical barrier separating your gut contents from your bloodstream. They communicate with dendritic cells and macrophages that set the inflammatory tone of the entire body.
When this system works well, inflammation is a targeted, proportionate, and self-resolving response. When it is chronically dysregulated — as it is in low-diversity, Western-pattern microbiomes — you get the low-grade, persistent inflammatory state that researchers now call inflammageing: the slow, smouldering immune activation that underlies cardiovascular disease, neurodegeneration, metabolic syndrome, and accelerated biological ageing.
Inflammageing is not a disease. It is a state. It does not announce itself. There is no fever, no obvious infection. But chronically elevated cytokines — IL-6, TNF-alpha, CRP — quietly erode tissue integrity, accelerate cellular senescence, and shorten health span. The microbiome is one of the most modifiable drivers of this state.
Metabolic Health: SCFAs, leaky gut, and glucose
Short-Chain Fatty Acids
When your gut bacteria ferment dietary fibre, they produce short-chain fatty acids — primarily butyrate, propionate, and acetate. These are not waste products. They are signalling molecules with profound systemic effects.
Butyrate is the primary fuel source for colonocytes (the cells lining your colon), promotes intestinal barrier integrity, inhibits histone deacetylases to regulate gene expression, and has demonstrated anti-inflammatory and anti-cancer properties. Propionate travels to the liver, where it influences lipid and glucose metabolism. Acetate crosses into circulation and is used as a substrate across multiple tissues including the brain.
People with depleted microbiomes — through antibiotic overuse, ultra-processed diets, or age-related changes — produce substantially less of these metabolites. The downstream effects show up as impaired insulin sensitivity, increased gut permeability, and elevated systemic inflammation. This is not a hypothetical mechanism. It is measurable in clinical practice.
Leaky Gut and Zonulin
The gut epithelium is a single-cell-thick barrier held together by tight junction proteins — claudins, occludins, and the now well-studied zonulin. Zonulin, first characterised by Dr. Alessio Fasano and colleagues, is the primary physiological regulator of intestinal tight junction permeability. When zonulin is chronically elevated — triggered by gliadin (a component of gluten), lipopolysaccharides from gram-negative bacteria, or frank dysbiosis — tight junctions loosen.
The result is increased intestinal permeability: bacterial fragments, undigested food antigens, and lipopolysaccharides enter systemic circulation. The immune system mounts a response. Endotoxaemia — even at low, subclinical levels — is now associated with metabolic syndrome, non-alcoholic fatty liver disease, type 2 diabetes, and neuroinflammation. Fasano's research group has published extensively on zonulin as a serum biomarker, and elevated zonulin correlates with a range of autoimmune and metabolic conditions.
Eran Segal's lab at the Weizmann Institute published a landmark 2015 paper in Cell demonstrating that postprandial glycaemic responses to identical foods vary enormously between individuals — and that this variation is significantly predicted by gut microbiome composition. Two people eating the same meal can have wildly different blood glucose responses. The microbiome was a better predictor of this variation than calorie content or carbohydrate load. This work fundamentally challenged the idea of a universal glycaemic index and demonstrated that personalised nutrition, guided by microbiome profiling, could meaningfully reduce glycaemic variability — a key driver of metabolic ageing.
Akkermansia muciniphila: the bacterium that earns its mention
If there is one bacterial species that has attracted sustained, serious scientific attention in the longevity context, it is Akkermansia muciniphila. Named for the Dutch microbiologist Antoon Akkermans, it is a gram-negative, anaerobic bacterium that lives in the mucus layer of the colon and constitutes roughly 1 to 4 percent of the gut microbiota in healthy adults.
What makes Akkermansia notable is what it does. It degrades and renews the mucus layer, stimulating goblet cells to produce fresh mucin and thereby maintaining a robust physical barrier. It produces Amuc_1100, an outer membrane protein that directly interacts with Toll-like receptor 2 on intestinal cells, promoting tight junction integrity and dampening inflammatory signalling.
In human studies, higher Akkermansia abundance is consistently associated with leaner metabolic profiles, better insulin sensitivity, and lower markers of systemic inflammation. Crucially, Akkermansia levels decline markedly with age, with obesity, with antibiotic use, and with Western dietary patterns. A 2019 study by Plovier and Cani et al. demonstrated that pasteurised Akkermansia (inactivated but with intact membrane proteins) was safe and effective in humans at improving metabolic markers — an early signal that therapeutic restoration of this species may be feasible.
What increases Akkermansia? The evidence most consistently supports polyphenol-rich foods (pomegranate, cranberry, grape seed), omega-3 fatty acids, and intermittent fasting. Interestingly, metformin — the widely used diabetes and longevity drug — also increases Akkermansia abundance, which may contribute to some of its metabolic benefits. This is an active area of research.
Microbiome Diversity as a Longevity Marker
Across the longitudinal and cross-sectional studies examining healthy ageing, one signal is remarkably consistent: centenarians and supercentenarians have significantly more diverse gut microbiomes than younger, less healthy age-matched peers. This holds across cohorts in China, Italy, Japan, and Sardinia — some of the most-studied longevity populations in the world.
Diversity here means both alpha diversity (the variety of species within an individual's gut) and the relative abundance of specific beneficial species. What we see in healthy hundred-year-olds is not just more microbes — it is a particular pattern: enrichment of Akkermansia, Bifidobacterium, Lactobacillus, and Faecalibacterium prausnitzii alongside depletion of pro-inflammatory, opportunistic species.
Faecalibacterium prausnitzii deserves a brief mention here. It is one of the most abundant butyrate producers in the human gut and a potent anti-inflammatory species. Low levels of F. prausnitzii are found consistently in inflammatory bowel disease, colorectal cancer, and metabolic syndrome. Like Akkermansia, it declines with age and with antibiotic exposure. Like Akkermansia, it responds to dietary intervention — particularly to fermentable fibres such as inulin and pectin.
How the Microbiome Changes with Age: dysbiosis is not inevitable
Ageing is accompanied by predictable shifts in the gut microbiome, but it is important to disentangle what is biologically inevitable from what is driven by lifestyle, medication, and environment — because the latter can be addressed.
In general terms, the ageing microbiome shows a decrease in diversity, a reduction in beneficial short-chain fatty acid producers, an increase in opportunistic and proteolytic species, and an increase in lipopolysaccharide-producing gram-negative bacteria. These shifts correlate with — and in some models precede — the metabolic and inflammatory features of ageing.
- Reduced gastric acid production in older adults allows bacteria to colonise regions of the gut they should not normally reach, altering composition upstream.
- Slower intestinal transit changes fermentation dynamics, favouring protein-fermenting species that produce branched-chain fatty acids and hydrogen sulphide over the carbohydrate-fermenting butyrate producers.
- Polypharmacy — common in older adults — has significant microbiome-altering effects. Antibiotics are the obvious culprit, but proton pump inhibitors, metformin, NSAIDs, and statins all have documented effects on gut microbial composition.
- Dietary narrowing — eating less variety, less fibre, less fermented food — directly reduces the substrate available to maintain a diverse ecosystem.
The critical point is that highly healthy older adults — people ageing well, with preserved cognitive and metabolic function — show gut microbiome profiles that more closely resemble younger adults than they do their sick age-matched peers. This is not coincidence. The microbiome appears to be both a mediator and a marker of biological versus chronological age.
The Sonnenburg Lab's research in traditional populations adds an important dimension here. Studies of the Hadza hunter-gatherers in Tanzania, who eat a diet with vastly more fibre and microbial exposure than Western populations, show microbiome diversity on a different scale entirely — and virtually absent rates of the inflammatory chronic diseases that drive most of our mortality. This is not nostalgia for a lost world. It is data. It tells us how far the modern gut has drifted from its evolutionary baseline, and why that drift has consequences.
What Actually Moves the Needle
This is the section most people want — and the one where honesty is most needed. The supplement industry has colonised the gut health conversation in ways that can obscure what the evidence actually says. So let me be direct.
Diet: the primary lever
There is no credible substitute for dietary fibre diversity and fermented foods. The Sonnenburg Lab's work consistently shows that diversity of plant intake — not just quantity of fibre — is the strongest predictor of microbiome diversity. Aim for 30 or more distinct plant foods per week, across vegetables, fruits, legumes, nuts, seeds, herbs, and wholegrains. Each brings a distinct set of fibres that feeds different microbial communities.
Fermented foods — live-culture yoghurt, kefir, kimchi, sauerkraut, miso, tempeh — directly seed the gut with beneficial organisms and have demonstrated effects on both microbiome diversity and inflammatory markers in randomised trials. This is distinct from probiotic supplements, which deliver narrow-spectrum organisms in quantities and strains that often do not persist long-term in the gut ecosystem.
Probiotics: useful, but misunderstood
Probiotic supplements have their place — particularly for specific clinical indications (antibiotic-associated diarrhoea, certain IBS phenotypes, post-surgical gut restoration) and specific, well-studied strains. But the idea that taking a daily probiotic capsule meaningfully and durably alters the composition of your gut microbiome is not well-supported. Most supplemental strains do not colonise — they transit. The benefit, where it exists, often comes from their metabolic activity during that transit, not from permanent settlement.
The gut is an ecosystem. You cannot meaningfully change a forest by planting one species in depleted soil. You have to change the soil conditions — which means diet.
Sleep and circadian rhythm
The gut microbiome has its own circadian oscillation, governed by the timing of food intake and light exposure. Disrupted sleep and late-night eating have documented negative effects on gut microbial composition and metabolic function. In one much-cited study, just two days of sleep deprivation measurably shifted the microbiome toward inflammatory species. This is a two-way relationship: a dysbiotic gut also impairs sleep quality, partly through disrupted serotonin and GABA signalling.
Exercise
Regular physical activity — particularly aerobic exercise — is independently associated with higher microbial diversity and elevated Akkermansia and butyrate-producing species. These effects appear to be direct, not simply mediated through changes in diet or body weight. The mechanisms likely involve enhanced colonic motility, reduced systemic cortisol, and improved gut blood flow.
Stress and the HPA axis
Chronic psychological stress alters gut motility, intestinal permeability, and secretory IgA — the antibody that lines the gut and shapes which organisms are permitted to flourish. Elevated cortisol disrupts the epithelial tight junctions that zonulin was already loosening. This is a physiologically plausible, and now well-documented, mechanism by which chronic stress ages the gut and, through it, the body.
What about faecal microbiota transplantation (FMT)? This remains a frontier area for longevity. In ageing mouse models, FMT from young donors to old recipients has reversed aspects of gut and brain ageing with striking effect. In humans, FMT is currently regulated for recurrent Clostridioides difficile infection only. But the science of donor selection, delivery optimisation, and therapeutic application for metabolic and neurological conditions is advancing quickly. This is one to watch.
The Longyx Angle: assessing what is actually happening in your gut
In clinical practice, the gut is usually investigated only when something is visibly broken — when there is blood, pain, obstruction, or an endoscopically detectable lesion. By those criteria, most of my patients have "normal" guts. But the question that matters in longevity medicine is not whether your gut is sick by conventional metrics. It is whether it is functioning optimally — and at what rate the microbial ecosystem it hosts is contributing to your biological ageing.
At Longyx, gut health markers are a core component of the longevity assessment. This includes:
- Gut microbiome profiling — characterising diversity, species abundance, and keystone organism status (including Akkermansia, F. prausnitzii, and Bifidobacterium).
- Intestinal permeability markers — including zonulin, lipopolysaccharide-binding protein (LBP), and secretory IgA, which together give a picture of barrier integrity and mucosal immune status.
- Inflammatory correlates — high-sensitivity CRP, IL-6, and other cytokine markers that reflect the systemic output of gut immune dysregulation.
- Metabolic markers — fasting insulin, HOMA-IR, continuous glucose data where relevant, and lipid fractionation — all of which are downstream of gut microbial metabolic activity.
- Stool inflammatory markers — calprotectin and lactoferrin to detect mucosal inflammation that may not be apparent systemically.
This data does not exist in isolation. It is interpreted alongside your full biological age assessment — epigenetic age, cardiovascular risk markers, hormonal and mitochondrial function, and cognitive performance. The gut is one system within an interconnected physiology, and we treat it that way.
What changes when you have this picture? You can make targeted, evidence-based interventions rather than generic wellness advice. You can track whether those interventions are working — not just symptomatically, but at the level of microbial composition and downstream biomarkers. And you can do it before dysfunction becomes disease.
That, to me, is the practical promise of this science: not that the microbiome is magic, but that it is measurable — and that what is measurable can be changed.
A Final Note
The human microbiome is one of the great scientific discoveries of the last twenty years. We are nowhere near understanding it fully. New species are still being characterised, new metabolic pathways described, new connections between gut composition and seemingly unrelated diseases established on a regular basis. I hold this science with appropriate humility.
But we know enough — right now, with the evidence already published — to say with confidence that the diversity and composition of your gut microbiome is one of the most powerful modulators of how you age. We know that diet, sleep, exercise, and stress all write directly into this ecosystem. And we know that the changes we can make in this domain are among the most tractable and durable in all of preventive medicine.
That is not a small thing. That is, I would argue, one of the more hopeful findings in the entire longevity literature.